Tegoyes 5.8mg/15.8mg/20mg Capsule
By Tegoyes
Rx
7 Capsule in a Strip

Composition
Gimeracil(5.8mg) + Oteracil(15.8mg) + Tegafur(20mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
September, 2025

liver
Tegoyes 5.8mg/15.8mg/20mg Capsule is considered safe for use in patients with liver disease. It has been determined that no dose adjustment of Tegoyes 5.8mg/15.8mg/20mg Capsule is necessary specifically for individuals with liver issues. It is important to note that the safety profile of Tegoyes 5.8mg/15.8mg/20mg Capsule remains favorable in relation to liver health. If you have concerns or specific questions about using Tegoyes 5.8mg/15.8mg/20mg Capsule with liver conditions, it is always best to consult with your doctor for personalized guidance.

kidney
Tegoyes 5.8mg/15.8mg/20mg Capsule requires caution in kidney disease patients. Dosage adjustment may be necessary. Seek advice from your doctor.

alcohol
It is not known whether it is safe to consume alcohol with Tegoyes 5.8mg/15.8mg/20mg Capsule. Please consult your doctor.

driving
When using Tegoyes 5.8mg/15.8mg/20mg Capsule, it is important to note that it may cause side effects that can impact driving. These side effects include fatigue, dizziness, blurred vision, and nausea, especially when used with cisplatin.

pregnancy
Tegoyes 5.8mg/15.8mg/20mg Capsule is not safe for use during pregnancy due to the risk it poses to the developing baby. However, in rare life-threatening cases, a doctor may prescribe it if the benefits outweigh the risks. It is important to consult your doctor before taking this medication.

breastfeeding
Tegoyes 5.8mg/15.8mg/20mg Capsule should not be used while breastfeeding due to potential harm to the baby from drug toxicity.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹3600
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025